{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:39:09Z","timestamp":1793835549093,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:00:00Z","timestamp":1507680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Studies in murine cell lines and in mouse models suggest that IL-15 promotes myogenesis and may protect against the inflammation-mediated skeletal muscle atrophy which occurs in sarcopenia and cachexia. The effects of IL-15 on human skeletal muscle growth and development remain largely uncharacterised. Myogenic cultures were isolated from the skeletal muscle of young and elderly subjects. Myoblasts were differentiated for 8 d, with or without the addition of recombinant cytokines (rIL-15, rTNF\u03b1) and an IL-15 receptor neutralising antibody. Although myotubes were 19% thinner in cultures derived from elderly subjects, rIL-15 increased the thickness of myotubes (MTT) from both age groups to a similar extent. Neutralisation of the high-affinity IL-15 receptor binding subunit, IL-15r\u03b1 in elderly myotubes confirmed that autocrine concentrations of IL-15 also support myogenesis. Co-incubation of differentiating myoblasts with rIL-15 and rTNF\u03b1, limited the reduction in MTT and nuclear fusion index (NFI) associated with rTNF\u03b1 stimulation alone. IL-15r\u03b1 neutralisation and rTNF\u03b1 decreased MTT and NFI further. This, coupled with our observation that myotubes secrete IL-15 in response to TNF\u03b1 stimulation supports the notion that IL-15 serves to mitigate inflammatory skeletal muscle loss. IL-15 may be an effective therapeutic target for the attenuation of inflammation-mediated skeletal muscle atrophy.<\/jats:p>","DOI":"10.1038\/s41598-017-13479-w","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T13:10:28Z","timestamp":1507209028000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["IL-15 promotes human myogenesis and mitigates the detrimental effects of TNF\u03b1 on myotube development"],"prefix":"10.1038","volume":"7","author":[{"given":"Mary F.","family":"O\u2019Leary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham R.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Tsintzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon W.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,11]]},"reference":[{"key":"13479_CR1","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.2337\/dc10-0107","volume":"33","author":"S Lim","year":"2010","unstructured":"Lim, S. et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care \n                           33, 1652\u20131654 (2010).","journal-title":"Diabetes Care"},{"key":"13479_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060119","volume":"8","author":"SO Chin","year":"2013","unstructured":"Chin, S. O. et al. Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009. PloS One \n                           8, e60119 (2013).","journal-title":"PloS One"},{"key":"13479_CR3","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1126\/science.8178155","volume":"264","author":"KH Grabstein","year":"1994","unstructured":"Grabstein, K. H. et al. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science \n                           264, 965\u2013968 (1994).","journal-title":"Science"},{"key":"13479_CR4","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1073\/pnas.91.11.4935","volume":"91","author":"JD Burton","year":"1994","unstructured":"Burton, J. D. et al. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc. Natl. Acad. Sci. USA. \n                           91, 4935\u20134939 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"13479_CR5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jlb.57.5.763","volume":"57","author":"JG Giri","year":"1995","unstructured":"Giri, J. G. et al. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J. Leukoc. Biol. \n                           57, 763\u2013766 (1995).","journal-title":"J. Leukoc. Biol."},{"key":"13479_CR6","doi-asserted-by":"crossref","unstructured":"Ali, A. K., Nandagopal, N. & Lee, S.-H. IL-15\u2013PI3K\u2013AKT\u2013mTOR: A Critical Pathway in the Life Journey of Natural Killer Cells. Front. Immunol. 6, (2015).","DOI":"10.3389\/fimmu.2015.00355"},{"key":"13479_CR7","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1210\/endo.136.8.7628408","volume":"136","author":"LS Quinn","year":"1995","unstructured":"Quinn, L. S., Haugk, K. L. & Grabstein, K. H. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology \n                           136, 3669\u20133672 (1995).","journal-title":"Endocrinology"},{"key":"13479_CR8","first-page":"471","volume":"16","author":"S Busquets","year":"2005","unstructured":"Busquets, S. et al. Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect. Int. J. Mol. Med. \n                           16, 471\u2013476 (2005).","journal-title":"Int. J. Mol. Med."},{"key":"13479_CR9","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4046\/trd.2012.73.6.312","volume":"73","author":"HC Kim","year":"2012","unstructured":"Kim, H. C., Cho, H.-Y. & Hah, Y.-S. Role of IL-15 in Sepsis-Induced Skeletal Muscle Atrophy and Proteolysis. Tuberc. Respir. Dis. \n                           73, 312\u2013319 (2012).","journal-title":"Tuberc. Respir. Dis."},{"key":"13479_CR10","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1054\/bjoc.2000.1299","volume":"83","author":"N Carb\u00f3","year":"2000","unstructured":"Carb\u00f3, N. et al. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br. J. Cancer \n                           83, 526\u2013531 (2000).","journal-title":"Br. J. Cancer"},{"key":"13479_CR11","doi-asserted-by":"publisher","first-page":"C1298","DOI":"10.1152\/ajpcell.00496.2006","volume":"292","author":"EE Pistilli","year":"2007","unstructured":"Pistilli, E. E., Siu, P. M. & Alway, S. E. Interleukin-15 responses to aging and unloading-induced skeletal muscle atrophy. Am. J. Physiol. Cell Physiol. \n                           292, C1298\u20131304 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"13479_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00283","volume":"6","author":"T Snijders","year":"2015","unstructured":"Snijders, T. et al. Satellite cells in human skeletal muscle plasticity. Front. Physiol. \n                           6, 283 (2015).","journal-title":"Front. Physiol."},{"key":"13479_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jcsm.12043","volume":"6","author":"TS Bowen","year":"2015","unstructured":"Bowen, T. S., Schuler, G. & Adams, V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J. Cachexia Sarcopenia Muscle \n                           6, 197\u2013207 (2015).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"13479_CR14","doi-asserted-by":"publisher","first-page":"1123S","DOI":"10.3945\/ajcn.2010.28608A","volume":"91","author":"WJ Evans","year":"2010","unstructured":"Evans, W. J. Skeletal muscle loss: cachexia, sarcopenia, and inactivity. Am. J. Clin. Nutr. \n                           91, 1123S\u20131127S (2010).","journal-title":"Am. J. Clin. Nutr."},{"key":"13479_CR15","first-page":"1743","volume":"4","author":"J Nakashima","year":"1998","unstructured":"Nakashima, J. et al. Association between tumor necrosis factor in serum and cachexia in patients with prostate cancer. Clin. Cancer Res. \n                           4, 1743\u20131748 (1998).","journal-title":"Clin. Cancer Res."},{"key":"13479_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0167-5273(96)02873-2","volume":"58","author":"SP Zhao","year":"1997","unstructured":"Zhao, S. P. & Zeng, L. H. Elevated plasma levels of tumor necrosis factor in chronic heart failure with cachexia. Int. J. Cardiol. \n                           58, 257\u2013261 (1997).","journal-title":"Int. J. Cardiol."},{"key":"13479_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nmeth.1314","volume":"6","author":"EK Schmidt","year":"2009","unstructured":"Schmidt, E. K., Clavarino, G., Ceppi, M. & Pierre, P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods \n                           6, 275\u2013277 (2009).","journal-title":"Nat. Methods"},{"key":"13479_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/JES.0b013e3182798a95","volume":"41","author":"CA Goodman","year":"2013","unstructured":"Goodman, C. A. & Hornberger, T. A. Measuring protein synthesis with SUnSET: a valid alternative to traditional techniques? Exerc. Sport Sci. Rev. \n                           41, 107\u2013115 (2013).","journal-title":"Exerc. Sport Sci. Rev."},{"key":"13479_CR19","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1172\/JCI44945","volume":"121","author":"EE Pistilli","year":"2011","unstructured":"Pistilli, E. E. et al. Loss of IL-15 receptor \u03b1 alters the endurance, fatigability, and metabolic characteristics of mouse fast skeletal muscles. J. Clin. Invest. \n                           121, 3120\u20133132 (2011).","journal-title":"J. Clin. Invest."},{"key":"13479_CR20","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1093\/intimm\/dxf062","volume":"14","author":"T Sugiura","year":"2002","unstructured":"Sugiura, T. et al. Increased IL-15 production of muscle cells in polymyositis and dermatomyositis. Int. Immunol. \n                           14, 917\u2013924 (2002).","journal-title":"Int. Immunol."},{"key":"13479_CR21","doi-asserted-by":"publisher","DOI":"10.1096\/fj.03-1228fje","author":"SW Jones","year":"2004","unstructured":"Jones, S. W. et al. Disuse atrophy and exercise rehabilitation in humans profoundly affects the expression of genes associated with the regulation of skeletal muscle mass. FASEB J. \n                           https:\/\/doi.org\/10.1096\/fj.03-1228fje (2004).","journal-title":"FASEB J."},{"key":"13479_CR22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1152\/jappl.2000.89.1.143","volume":"89","author":"S Trappe","year":"2000","unstructured":"Trappe, S. et al. Effect of resistance training on single muscle fiber contractile function in older men. J. Appl. Physiol. \n                           89, 143\u2013152 (2000).","journal-title":"J. Appl. Physiol."},{"key":"13479_CR23","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing \n                           39, 412\u2013423 (2010).","journal-title":"Age Ageing"},{"key":"13479_CR24","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.bbrc.2015.02.015","volume":"458","author":"GC O\u2019Connell","year":"2015","unstructured":"O\u2019Connell, G. C. & Pistilli, E. E. Interleukin-15 directly stimulates pro-oxidative gene expression in skeletal muscle in-vitro via a mechanism that requires interleukin-15 receptor alpha. Biochem. Biophys. Res. Commun. \n                           458, 614\u2013619 (2015).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"13479_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.intimp.2014.02.002","volume":"19","author":"D-T Wang","year":"2014","unstructured":"Wang, D.-T. et al. Resveratrol prevents TNF-\u03b1-induced muscle atrophy via regulation of Akt\/mTOR\/FoxO1 signaling in C2C12 myotubes. Int. Immunopharmacol. \n                           19, 206\u2013213 (2014).","journal-title":"Int. Immunopharmacol."},{"key":"13479_CR26","first-page":"196","volume":"17","author":"H Himmerich","year":"2006","unstructured":"Himmerich, H. et al. TNF-alpha, soluble TNF receptor and interleukin-6 plasma levels in the general population. Eur. Cytokine Netw. \n                           17, 196\u2013201 (2006).","journal-title":"Eur. Cytokine Netw."},{"key":"13479_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.18632\/aging.100482","volume":"4","author":"CT Lutz","year":"2012","unstructured":"Lutz, C. T. & Quinn, L. S. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging \n                           4, 535\u2013546 (2012).","journal-title":"Aging"},{"key":"13479_CR28","doi-asserted-by":"publisher","first-page":"C1660","DOI":"10.1152\/ajpcell.00486.2006","volume":"292","author":"S-E Chen","year":"2007","unstructured":"Chen, S.-E., Jin, B. & Li, Y.-P. TNF-\u03b1 regulates myogenesis and muscle regeneration by activating p38 MAPK. Am. J. Physiol. Cell Physiol. \n                           292, C1660\u2013C1671 (2007).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"13479_CR29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/S0140-6736(03)12892-9","volume":"361","author":"SD Anker","year":"2003","unstructured":"Anker, S. D. et al. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet Lond. Engl. \n                           361, 1077\u20131083 (2003).","journal-title":"Lancet Lond. Engl."},{"key":"13479_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/jcsm.12062","volume":"7","author":"KJC Sanders","year":"2016","unstructured":"Sanders, K. J. C., Kneppers, A. E. M., van de Bool, C., Langen, R. C. J. & Schols, A. M. W. J. Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective. J. Cachexia Sarcopenia Muscle \n                           7, 5\u201322 (2016).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"13479_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon, K. et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. \n                           12, 489\u2013495 (2011).","journal-title":"Lancet Oncol."},{"key":"13479_CR32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ijcard.2014.10.026","volume":"184","author":"S von Haehling","year":"2015","unstructured":"von Haehling, S. & Anker, S. D. Treatment of cachexia: An overview of recent developments. Int. J. Cardiol. \n                           184, 736\u2013742 (2015).","journal-title":"Int. J. Cardiol."},{"issue":"Spec No","key":"13479_CR33","first-page":"11","volume":"50","author":"J Lexell","year":"1995","unstructured":"Lexell, J. Human aging, muscle mass, and fiber type composition. J. Gerontol. A. Biol. Sci. Med. Sci. \n                           50(Spec No), 11\u201316 (1995).","journal-title":"J. Gerontol. A. Biol. Sci. Med. Sci."},{"key":"13479_CR34","doi-asserted-by":"crossref","first-page":"1011S","DOI":"10.1093\/jn\/127.5.1011S","volume":"127","author":"J Lexell","year":"1997","unstructured":"Lexell, J. Evidence for Nervous System Degeneration with Advancing Age. J. Nutr. \n                           127, 1011S\u20131013S (1997).","journal-title":"J. Nutr."},{"key":"13479_CR35","first-page":"211","volume":"72","author":"J Lexell","year":"1986","unstructured":"Lexell, J., Downham, D. & Sj\u00f6str\u00f6m, M. Distribution of different fibre types in human skeletal muscles. Fibre type arrangement in m. vastus lateralis from three groups of healthy men between 15 and 83 years. J. Neurol. Sci. \n                           72, 211\u2013222 (1986).","journal-title":"vastus lateralis from three groups of healthy men between 15 and 83 years. J. Neurol. Sci."},{"key":"13479_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ydbio.2006.02.022","volume":"294","author":"G Shefer","year":"2006","unstructured":"Shefer, G., V de Mark, D. P., Richardson, J. B. & Yablonka-Reuveni, Z. Satellite-cell pool size does matter: defining the myogenic potency of aging skeletal muscle. Dev. Biol. \n                           294, 50\u201366 (2006).","journal-title":"Dev. Biol."},{"key":"13479_CR37","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.exger.2016.01.008","volume":"76","author":"A Buch","year":"2016","unstructured":"Buch, A. et al. Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age - An overview. Exp. Gerontol. \n                           76, 25\u201332 (2016).","journal-title":"Exp. Gerontol."},{"key":"13479_CR38","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/jcp.21692","volume":"219","author":"P Rotwein","year":"2009","unstructured":"Rotwein, P. & Wilson, E. M. Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. J. Cell. Physiol. \n                           219, 503\u2013511 (2009).","journal-title":"J. Cell. Physiol."},{"key":"13479_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-1-29","volume":"1","author":"JD Knight","year":"2011","unstructured":"Knight, J. D. & Kothary, R. The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis. Skelet. Muscle \n                           1, 29 (2011).","journal-title":"Skelet. Muscle"},{"key":"13479_CR40","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1101\/gad.247205.114","volume":"28","author":"DP Millay","year":"2014","unstructured":"Millay, D. P., Sutherland, L. B., Bassel-Duby, R. & Olson, E. N. Myomaker is essential for muscle regeneration. Genes Dev. \n                           28, 1641\u20131646 (2014).","journal-title":"Genes Dev."},{"key":"13479_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nature12343","volume":"499","author":"DP Millay","year":"2013","unstructured":"Millay, D. P. et al. Myomaker is a membrane activator of myoblast fusion and muscle formation. Nature \n                           499, 301\u2013305 (2013).","journal-title":"Nature"},{"key":"13479_CR42","doi-asserted-by":"crossref","unstructured":"Goh, Q. & Millay, D. P. Requirement of myomaker-mediated stem cell fusion for skeletal muscle hypertrophy. eLife \n                           6 (2017).","DOI":"10.7554\/eLife.20007"},{"key":"13479_CR43","doi-asserted-by":"publisher","first-page":"26186","DOI":"10.3390\/ijms161125946","volume":"16","author":"W Luo","year":"2015","unstructured":"Luo, W., Li, E., Nie, Q. & Zhang, X. Myomaker, Regulated by MYOD, MYOG and miR-140-3p, Promotes Chicken Myoblast Fusion. Int. J. Mol. Sci. \n                           16, 26186\u201326201 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"13479_CR44","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1007\/s00018-013-1330-4","volume":"70","author":"N Zanou","year":"2013","unstructured":"Zanou, N. & Gailly, P. Skeletal muscle hypertrophy and regeneration: interplay between the myogenic regulatory factors (MRFs) and insulin-like growth factors (IGFs)pathways. Cell. Mol. Life Sci. CMLS \n                           70, 4117\u20134130 (2013).","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"13479_CR45","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3945\/ajcn.2008.26626","volume":"89","author":"LB Verdijk","year":"2009","unstructured":"Verdijk, L. B. et al. Protein supplementation before and after exercise does not further augment skeletal muscle hypertrophy after resistance training in elderly men. Am. J. Clin. Nutr. \n                           89, 608\u2013616 (2009).","journal-title":"Am. J. Clin. Nutr."},{"key":"13479_CR46","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1249\/MSS.0b013e318272fcdb","volume":"45","author":"M Leenders","year":"2013","unstructured":"Leenders, M. et al. Protein supplementation during resistance-type exercise training in the elderly. Med. Sci. Sports Exerc. \n                           45, 542\u2013552 (2013).","journal-title":"Med. Sci. Sports Exerc."},{"key":"13479_CR47","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/00005768-200207000-00023","volume":"34","author":"SJ Pearson","year":"2002","unstructured":"Pearson, S. J. et al. Muscle function in elite master weightlifters. Med. Sci. Sports Exerc. \n                           34, 1199\u20131206 (2002).","journal-title":"Med. Sci. Sports Exerc."},{"key":"13479_CR48","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1113\/jphysiol.2006.109892","volume":"575","author":"K Tsintzas","year":"2006","unstructured":"Tsintzas, K. et al. Differential regulation of metabolic genes in skeletal muscle during starvation and refeeding in humans. J. Physiol. \n                           575, 291\u2013303 (2006).","journal-title":"J. Physiol."},{"key":"13479_CR49","doi-asserted-by":"publisher","unstructured":"Agley, C. C., Rowlerson, A. M., Velloso, C. P., Lazarus, N. L. & Harridge, S. D. R. Isolation and quantitative immunocytochemical characterization of primary myogenic cells and fibroblasts from human skeletal muscle. J. Vis. Exp. JoVE 52049 (2015). https:\/\/doi.org\/10.3791\/52049","DOI":"10.3791\/52049"},{"key":"13479_CR50","first-page":"138","volume":"238","author":"B Pawlikowski","year":"2009","unstructured":"Pawlikowski, B., Lee, L., Zuo, J. & Kramer, R. Analysis of human muscle stem cells reveals a differentiation-resistant progenitor cell population expressing Pax7 capable of self-renewal. Dev. Dyn. Off. Publ. Am. Assoc. Anat. \n                           238, 138\u2013149 (2009).","journal-title":"Dev. Dyn. Off. Publ. Am. Assoc. Anat."},{"key":"13479_CR51","doi-asserted-by":"publisher","first-page":"5610","DOI":"10.1242\/jcs.132563","volume":"126","author":"CC Agley","year":"2013","unstructured":"Agley, C. C., Rowlerson, A. M., Velloso, C. P., Lazarus, N. R. & Harridge, S. D. R. Human skeletal muscle fibroblasts, but not myogenic cells, readily undergo adipogenic differentiation. J Cell Sci \n                           126, 5610\u20135625 (2013).","journal-title":"J Cell Sci"},{"key":"13479_CR52","unstructured":"Rasband, W. Image J. (U. S. National Institutes of Health)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13479-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13479-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13479-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T11:47:54Z","timestamp":1671796074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-13479-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,11]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["13479"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-13479-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,11]]},"assertion":[{"value":"8 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12997"}}